Analytical Data
-
Gene name
CRTAM
- Application
-
Alternative Names
CRTAM；Cytotoxic and regulatory T-cell molecule
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95727
-
Expression Region
18-286aa
-
AA Sequence
SLTNHTETIT VEEGQTLTLK CVTSLRKNSS LQWLTPSGFT IFLNEYPALK NSKYQLLHHS ANQLSITVPN VTLQDEGVYK CLHYSDSVST KEVKVIVLAT PFKPILEASV IRKQNGEEHV VLMCSTMRSK PPPQITWLLG NSMEVSGGTL HEFETDGKKC NTTSTLIIHT YGKNSTVDCI IRHRGLQGRK LVAPFRFEDL VTDEETASDA LERNSLSSQD PQQPTSTVSV TEDSSTSEID KEEKEQTTQD PDLTTEANPQ YLGLARKKS
-
Molecular Weight
59 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CRTAM (Coxsackie and Adenovirus Receptor-Related Transmembrane Protein) is a member of the immunoglobulin superfamily and plays a crucial role in immune regulation and cell communication. It is primarily expressed in lymphocytes and has been implicated in T-cell activation and the modulation of immune responses. Recent studies have highlighted its involvement in various physiological and pathological processes, including tumor immunity and viral infections. The interest in CRTAM as a target for vaccine development and immunotherapy is growing, as it may enhance the efficacy of immune responses against cancer cells and chronic viral infections. The recombination and expression of CRTAM protein provide a valuable tool for elucidating its structure-function relationships and for developing potential therapeutic strategies. By generating recombinant CRTAM, researchers aim to investigate its interactions with other immune cell receptors and signaling pathways, ultimately advancing our understanding of its role in the immune system and its potential as a therapeutic target.
